Zimmer Biomet Showcases New Product Innovation, Novel Digital Health Offering and Robotic Technology at AAOS 2017

PR Newswire — March 14, 2017

WARSAW, Ind., March 14, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE
and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced
plans to highlight its latest commercial offerings and preview its next
generation of technological innovations at the American Academy of Orthopaedic
Surgeons (AAOS) annual meeting this week in San Diego, CA. The Company’s
state-of-the-art booth (#4333) will feature an immersive and interactive tour of
its newly launched digital technology and clinical services offering, Zimmer
Biomet Signature Solutions, alongside more than 50 new products from its vast
and diversified portfolio.

“We’re proud and excited to showcase our most innovative new commercial
offerings to the largest gathering of orthopaedic professionals,” said David
Dvorak, President and CEO of Zimmer Biomet. “New this year is a virtual booth
experience designed to bring Zimmer Biomet Signature Solutions to life through a
guided tour, a sneak preview of our emerging robotics platform and other
technologies in our deep pipeline.”

Following is a snapshot of the key highlights being featured at the Zimmer
Biomet booth (#4333) at AAOS 2017:

— Zimmer Biomet Signature Solutions
o Guided tours through the virtual experience every 15 minutes. Members
of the press can reserve a spot by contacting Monica Kendrick at
— Robotic Technology
o Catch a glimpse of the future of personalization and intelligent
instrument technology through innovative robotics.i
— Knees
o Vanguard® Individualized Design (ID), advances soft tissue
preservation and balancing through independent medial and lateral
articular surface constraint and thickness options.
o OSSTM Orthopedic Salvage System, a comprehensive modular platform
providing surgeons with intraoperative flexibility often required
during limb salvage procedures.
o Persona® Medial Congruent® Bearing, designed to recreate more natural
feeling motion of the human knee by maximizing knee joint stability
while allowing mobility.
— Hips
o Hip Preservation portfolio of options designed to treat conditions
leading up to osteoarthritis and potentially preventing the need for
total hip replacement.
o Trabecular MetalTM acetabular cups, which National Joint Registry
analysis has recently shown are 21 percent less likely to be
re-revised due to infection (statistically significant,
o The latest in dual mobility, Microplasty® and revision implant options
designed to address the distinct needs of individual patients while
simplifying surgical workflow.
— Personalized Solutions
o A comprehensive technology-based portfolio of guides, tools and
software to support surgical planning, intraoperative guidance and
optimal component placement.
— Bone Cement
o StageOneTM and StageOne Select Spacer Molds, designed to mold a
temporary knee, hip and shoulder spacer for patients undergoing a two
stage revision due to an infected total joint.
— Diagnostics
o Synovasure® Laboratory Panel for the detection of Periprosthetic Joint
Infection (PJI), now includes Microbial ID. These diagnostic tests
provide a fast and easy method to diagnose PJI based on the flagship
test, which determines the concentration of Alpha Defensin in synovial
fluid. Microbial ID detects the presence of microbes in the synovial
fluid in a matter of hours.
— Extremities
o Vault Reconstruction System (VRS), the first commercially available
patient-matched glenoid implant, cleared to specifically treat
patients with severe glenoid bone loss and a deficient rotator cuff.
o L2LTM Radial Head System, a simple, smooth design solution for
replacing the proximal radial head in patients with fractures.
— Foot and Ankle
o Deformity correcting products available through our partnership with
Nextremity Solutions, Inc., including the Nextra® Hammertoe Correction
System, the MSP(TM) Metatarsal Shortening System and the Re+Line®
Bunion Correction System.
o Subchondroplasty® Procedure for foot and ankle surgery, a minimally
invasive outpatient intervention that addresses the defects associated
with subchondral bone marrow lesions.
— Trauma
o A.L.P.S.® Proximal Humerus Plating System, designed to minimize the
risk of complications commonly associated with proximal humerus
fractures, such as varus collapse, articular screw penetration and
subacromial impingement.
o N-Force Fixation System® with N-Force Blue, an augmented fixation
system, integrating fenestrated screws and a Bone Substitute Material
into a single construct to provide improved metaphyseal void fill and
increase structural support of the implant.
o RibFix Blu® Thoracic Fixation System, designed and used for the
stabilization and rigid fixation of fractures in the chest wall,
including sternal reconstructive surgical procedures, trauma or
planned osteotomies.
— Sports Medicine
o Quattro® Link, a knotless anchor that brings control and efficiency to
soft tissue repair.
o BioWickTM SureLock®, a rotator cuff implant that is an interpositional
bioresorbable scaffold wick.
o SpeedSnareTM Surgical Suture Passer, which allows the ability to pass
a suture through single or multiple ports.
o Gel-One® Cross-Linked Hyaluronate, the first low-volume
viscosupplement available in a single-injection formula, for the
treatment of pain in osteoarthritis of the knee that does not respond
adequately to other conservative treatments.
— Biologics
o nSTRIDE® Autologous Protein Solution (ex-US use only), a single-shot
autologous anti-inflammatory for treatment of knee osteoarthritis.
o AmnioFloTM, allograft derived from human amniotic fluid, for joint
cushioning and lubrication.
— Surgical
o The IntelliCart(TM) System Duo Fluid Carts, the foundation for
infectious waste technology with market-leading 34-liter capacity,
extra quiet vacuum pump, clog-free suction manifolds and portable
smoke evacuation.
o Bactisure(TM) Wound Lavage, clear, low-odor, aqueous solution designed
to remove structurally resistant forms of bacteria, including
biofilms, on all wound types.
o The VasoPress® System, reduces the risk of blood clots associated with
deep vein thrombosis by propelling the venous blood out of the deep
veins while patients are undergoing surgical procedures or immobile
for an extended period of time.
— Spine
o Mobi-C® Cervical Disc, the first cervical disc replacement device
approved for both one and two-level procedures.
o Vitality® Spinal Fixation System, an adaptable system designed for
spinal fixation in complex thoracolumbar procedures.
About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global
leader in musculoskeletal healthcare. We design, manufacture and market
orthopaedic reconstructive products; sports medicine, biologics, extremities and
trauma products; office based technologies; spine, craniomaxillofacial and
thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the
pace of innovation. Our products and solutions help treat patients suffering
from disorders of, or injuries to, bones, joints or supporting soft tissues.
Together with healthcare professionals, we help millions of people live better

We have operations in more than 25 countries around the world and sell products
in more than 100 countries. For more information, visit www.zimmerbiomet.com or
follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Cautionary Statement Regarding Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the
safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, but are not limited to, statements
concerning Zimmer Biomet’s expectations, plans, prospects, and product and
service offerings, including new product launches and potential clinical
successes. Such statements are based upon the current beliefs and expectations
of management and are subject to significant risks and uncertainties that could
cause actual outcomes and results to differ materially. For a list and
description of some of such risks and uncertainties, see our periodic reports
filed with the SEC. These factors should not be construed as exhaustive and
should be read in conjunction with the other cautionary statements that are
included in Zimmer Biomet’s filings with the SEC. We disclaim any intention or
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as may be set
forth in our periodic reports. Accordingly, such forward-looking statements
speak only as of the date made. Readers of this news release are cautioned not
to place undue reliance on these forward-looking statements, since, while
management believes the assumptions on which the forward-looking statements are
based are reasonable, there can be no assurance that these forward-looking
statements will prove to be accurate. This cautionary statement is applicable to
all forward-looking statements contained in this news release.

i Concept device – not for sale in the US

ii 1. According to NJR data from 2003 to 2015 where 9,573 Trabecular Metal and
30,452 non-Trabecular Metal cups were used in revision THA and based on hazard
ratios adjusted by patient gender, age group, and indications (OA/non-OA).

2. NJR data shows a higher percentage of TM cups were used with antibiotic bone
cement compared to all other non-TM cementless cups.

To view the original version on PR Newswire,

SOURCE Zimmer Biomet Holdings, Inc.

Subject Codes: PC/t.170314163000788, PT/lang.en, PC/ticker, IN/HEA,
IN/MTC, SU/FVT, SU/TDS, RE/Indiana, RE/California,
PC/priority.r, PC/category.f, PC/DataFeat_indpr,
PC/port_32, PC/class.1245, PC/WAVO_….h., PC/APT_….h,
PC/trade_h, PC/wavo5_h, PC/class.1030, PC/WAVO_l…..,
PC/APT_l…., PC/state_l, PC/wavo1_l, PC/Billing_EML,
PC/Billing_INI, PC/Billing_RWB, PC/Billing_TNW,
PC/1stAcc_901036, PC/OtherAcc_643307, PC/bureau_DE,
PC/port_01, PC/port_96, PC/port_31, PC/port_19,
PC/port_91, PC/contact, PC/website, PC/photo,

Company Codes: NYSE:ZBH, Swiss:ZBH

Leave a Reply

Fatal error: Call to undefined function show_subscription_checkbox() in /home3/steer/public_html/indianapressreleases.com/wp-content/themes/comfy/comments.php on line 95